6533b85bfe1ef96bd12ba18e
RESEARCH PRODUCT
Models for non-alcoholic fatty liver disease: a link with vascular risk.
CalvarusoPinelopi ManousouElias XirouchakisSergio MaimoneM. PleguezueloDavid PatchA SigalasA CorbaniA.k. Burroughssubject
medicine.medical_specialtyDiseasedigestive systemGastroenterologyInsulin resistanceNAFLD central obesity dyslipidaemia insulin resistance/type 2Risk FactorsInternal medicineDrug DiscoveryAnimalsHumansMedicineVascular DiseasesRisk factorPharmacologybusiness.industryFatty livernutritional and metabolic diseasesType 2 Diabetes Mellitusmedicine.diseasedigestive system diseasesFatty LiverDisease Models AnimalEndocrinologyInflammation MediatorsSteatosisMetabolic syndromeSteatohepatitisbusinessdescription
Non alcoholic fatty liver disease (NAFLD) is often part of the metabolic syndrome which includes central obesity, dyslipidaemia, insulin resistance/type 2 diabetes mellitus and hypertension. In turn, NAFLD may be associated with an increased vascular risk. Several experimental models which express histological steatosis or steatohepatitis with fibrosis have been described. This review identifies those models of NAFLD with features of vascular risk.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2008-01-01 |